This Company has developed a Personalized App to Fight Cancer

We say goodbye to the good weather in Spain and cross the Pyrenees to visit Charleroi, an industrial city south of Brussels. There, we find OncoDNA, a young company striving to change the oncology field using DNA.

City: Charleroi, Belgium

Founded: 2012

Employees: 11 – 50

Financial data: €7.7M raised in September to expand into the global market

Mission: OncoDNA uses next-generation sequencing to analyze major DNA mutations in cancer and match the patient with a personalized treatment option. The coolest part is that the whole process can be controlled via a mobile app with a pretty neat design. On April, the company launched OncoTRACE, the first non-invasive personalized test to monitor tumor progression.

Comment: OncoDNA could pass for the smaller sibling of Foundation Medicine in the US. Jean-Pol Detiffe, its CEO, will be speaking at Labiotech Refresh this November. Don’t miss it!

Organoids in cancer research: Paving the way for faster drug development across cancer indications

This webinar explores how patient-derived organoids (PDOs) are redefining oncology research. Discover how advanced, well-characterized models empower researchers to streamline candidate selection, accelerate orphan drug programs, and deliver transformative therapies to patients faster than ever.

Watch now